Correlation Between Short Oil and Pharmaceuticals Ultrasector

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Short Oil and Pharmaceuticals Ultrasector at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Short Oil and Pharmaceuticals Ultrasector into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Short Oil Gas and Pharmaceuticals Ultrasector Profund, you can compare the effects of market volatilities on Short Oil and Pharmaceuticals Ultrasector and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Short Oil with a short position of Pharmaceuticals Ultrasector. Check out your portfolio center. Please also check ongoing floating volatility patterns of Short Oil and Pharmaceuticals Ultrasector.

Diversification Opportunities for Short Oil and Pharmaceuticals Ultrasector

-0.57
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Short and Pharmaceuticals is -0.57. Overlapping area represents the amount of risk that can be diversified away by holding Short Oil Gas and Pharmaceuticals Ultrasector Pr in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pharmaceuticals Ultrasector and Short Oil is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Short Oil Gas are associated (or correlated) with Pharmaceuticals Ultrasector. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pharmaceuticals Ultrasector has no effect on the direction of Short Oil i.e., Short Oil and Pharmaceuticals Ultrasector go up and down completely randomly.

Pair Corralation between Short Oil and Pharmaceuticals Ultrasector

Assuming the 90 days horizon Short Oil Gas is expected to under-perform the Pharmaceuticals Ultrasector. But the mutual fund apears to be less risky and, when comparing its historical volatility, Short Oil Gas is 1.63 times less risky than Pharmaceuticals Ultrasector. The mutual fund trades about -0.06 of its potential returns per unit of risk. The Pharmaceuticals Ultrasector Profund is currently generating about 0.09 of returns per unit of risk over similar time horizon. If you would invest  2,208  in Pharmaceuticals Ultrasector Profund on April 28, 2025 and sell it today you would earn a total of  212.00  from holding Pharmaceuticals Ultrasector Profund or generate 9.6% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Short Oil Gas  vs.  Pharmaceuticals Ultrasector Pr

 Performance 
       Timeline  
Short Oil Gas 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Short Oil Gas has generated negative risk-adjusted returns adding no value to fund investors. In spite of fairly strong forward indicators, Short Oil is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.
Pharmaceuticals Ultrasector 

Risk-Adjusted Performance

Modest

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Pharmaceuticals Ultrasector Profund are ranked lower than 6 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly weak forward indicators, Pharmaceuticals Ultrasector may actually be approaching a critical reversion point that can send shares even higher in August 2025.

Short Oil and Pharmaceuticals Ultrasector Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Short Oil and Pharmaceuticals Ultrasector

The main advantage of trading using opposite Short Oil and Pharmaceuticals Ultrasector positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Short Oil position performs unexpectedly, Pharmaceuticals Ultrasector can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pharmaceuticals Ultrasector will offset losses from the drop in Pharmaceuticals Ultrasector's long position.
The idea behind Short Oil Gas and Pharmaceuticals Ultrasector Profund pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.

Other Complementary Tools

Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk